THE EFFECT OF OMI THERAPY ON THE POWER OF THE LEG-STRETCHING MUSCLES IN PATIENTS SUFFERING FROM MULTIPLE SCLEROSIS.

In cases of multiple sclerosis, it has always been shown by the world of medical science that magnetic field therapies are the most effective physiotherapy options for the condition. Throughout the course of this study, we measured the effect of OMI therapy on extensor muscle strength in the lower limbs. At stage 0, irrespective of age, gender, SM type and illness phase, we carried out a physical examination, an EDSS invalidity test specific for multiple sclerosis, an FIM (functional independence measure) test for assessing disability, a Multicont II computer dynamometry examination to measure muscle strength and a video recording to show the patient‘s movement coordination. We looked at muscle strength in the lower limbs isometrically by measuring the maximum voluntary torque. We subsequently administered OMI therapy for six weeks and then repeated the afore-mentioned measurements and examinations. During these six weeks, we did not change anything in terms of pharmacotherapy, lifestyle or frequency of remedial gymnastics. We compared the results with the patients‘ initial condition and their own opinions. The changes in muscle strength measured in the lower limbs led to us to conclude that OMI therapy did have a beneficial effect for the patients.

THE EFFECT OF OMI THERAPY ON THE SEVERITY OF FATIGUE IN PATIENTS SUFFERING FROM MULTIPLE SCLEROSIS

Fatigue is a syndrome associated with many neurological conditions. In this study, fatigue syndrome in patients with multiple sclerosis was investigated.
21 patients with confirmed multiple sclerosis and fatigue syndrome were treated with a real device and 20 patients with an ineffective blind device. The patients were examined using a battery of tests at the beginning of treatment, after six weeks and after 12 weeks. The investigation was carried out in a double-blind manner.

It was shown that those patients treated with the genuine device recorded significant improvements in their target parameters of MFIS and FFS. The same trend was revealed in the crossover design.

In the Fatigue Study, we were therefore able to show that impulse therapy using the OMI signal resulted in a significant improvement in the fatigue symptoms of those suffering from multiple sclerosis.